Defining Outcomes for β-Cell Replacement Therapy in the Treatment of Diabetes: a Consensus Report on the Igls Criteria from the IPITA/EPITA Opinion Leaders Workshop. (Q51741299)
Jump to navigation
Jump to search
scientific article published on 9 March 2018
Language | Label | Description | Also known as |
---|---|---|---|
English | Defining Outcomes for β-Cell Replacement Therapy in the Treatment of Diabetes: a Consensus Report on the Igls Criteria from the IPITA/EPITA Opinion Leaders Workshop. |
scientific article published on 9 March 2018 |
Statements
Defining Outcomes for β-cell Replacement Therapy in the Treatment of Diabetes: A Consensus Report on the Igls Criteria From the IPITA/EPITA Opinion Leaders Workshop (English)
Barbara Ludwig
Johann Pratschke
Michael R Rickels
Peter G Stock
Eelco J P de Koning
Rodolfo Alejandro
Thierry Berney
Paul R Johnson
Raja Kandaswamy
Thomas W H Kay
Yogish C Kudva
Esther Latres
Robert M Langer
Roger Lehmann
James F Markmann
Marjana Marinac
François Pattou
James A M Shaw
Marie-Christine Vantyghem
Steven White
Melena D Bellin
1 September 2018
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference